BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 545722)

  • 1. Phenotype and surface antigens of mouse teratocarcinoma x fibroblast cell hybrids.
    Rousset JP; Dubois P; Lasserre C; Avilès D; Fellous M; Jami J
    Somatic Cell Genet; 1979 Nov; 5(6):739-52. PubMed ID: 545722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental potentialities and surface antigens of mouse teratocarcinoma x lymphoid cell hybrids.
    Rousset JP; Jami J; Dubois P; Avilès D; Ritz E
    Somatic Cell Genet; 1980 May; 6(3):419-33. PubMed ID: 7404272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent regulation of H-2K and H-2D gene expression in murine teratocarcinoma somatic cell hybrids.
    Gmür R; Solter D; Knowles BB
    J Exp Med; 1980 Jun; 151(6):1349-59. PubMed ID: 7381363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen expression by somatic cell hybrids of a murine embryonal carcinoma cell with thymocytes and L cells.
    Andrews PW; Goodfellow PN
    Somatic Cell Genet; 1980 Mar; 6(2):271-84. PubMed ID: 6994266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the teratocarcinoma phenotype in hybrids between totipotent mouse teratocarcinoma and myeloma cells.
    Correani A; Croce CM
    J Cell Physiol; 1980 Oct; 105(1):73-9. PubMed ID: 7430268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reexpression of a T/t-complex antigen (t12) in thymocyte x embryonal carcinoma cell hybrids.
    Artzt K; Jacobs-Cohen RJ; DiMeo A; Alton AK; Darlington G
    Somatic Cell Genet; 1981 Jul; 7(4):423-34. PubMed ID: 7025272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered differentiation, indefinite growth potential, diminished tumorigenicity, and suppressed chimerization potential of hybrids between mouse teratocarcinoma cells and thymocytes.
    Martin GM; Ogburn CE; Au K; Disteche CM
    J Exp Pathol; 1984; 1(2):103-33. PubMed ID: 6599936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation in vitro of human-mouse teratocarcinoma hybrids.
    Benham FJ; Wiles MV; Goodfellow PN
    Mol Cell Biol; 1983 Dec; 3(12):2259-70. PubMed ID: 6686281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supermelanotic hybrids between mouse teratocarcinoma and mouse melanoma cells.
    Watanabe T
    Exp Cell Res; 1984 Oct; 154(2):625-31. PubMed ID: 6479244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential H-2 antigen expression in teratocarcinoma-fibroblast hybrids.
    Sionov RV; Gallily R
    Exp Clin Immunogenet; 1995; 12(4):238-44. PubMed ID: 8919356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomes in tumors derived from mouse tumor x diploid cell hybrids obtained in vitro.
    Avilès D; Ritz E; Jami J
    Somatic Cell Genet; 1980 Mar; 6(2):171-86. PubMed ID: 6967231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of teratocarcinoma-thymus somatic cell hybrids.
    Miller RA; Ruddle FH
    Somatic Cell Genet; 1977 May; 3(3):247-61. PubMed ID: 605385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of chromosome segregation in Chinese hamster x mouse cell hybrids between permanent cell lines and thymus cells.
    Lasserre C; Jami J; Aviles D
    J Cell Physiol; 1980 Sep; 104(3):403-13. PubMed ID: 7419611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental characteristics of somatic cell hybrids between totipotent mouse teratocarcinoma and rat intestinal villus cells.
    van der Kamp AW; Roza-de Jongh EJ; Houwen RH; Magrane GG; van Dongen JM; Evans MJ
    Exp Cell Res; 1984 Sep; 154(1):53-64. PubMed ID: 6381077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of early antigenic changes on heterokaryons between L-cells and a teratocarcinoma-derived cell line, TerC.
    Searls DB
    Somatic Cell Genet; 1982 Sep; 8(5):587-604. PubMed ID: 7135164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of expression of histocompatibility antigens (H-2) and beta 2-microglobulin in F9 teratocarcinoma stem cells.
    Croce CM; Linnenbach A; Huebner K; Parnes JR; Margulies DH; Appella E; Seidman JG
    Proc Natl Acad Sci U S A; 1981 Sep; 78(9):5754-8. PubMed ID: 6170985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of teratocarcinoma-derived hemoglobin genes in teratocarcinoma-Friend cell hybrids.
    McBurney MW; Featherstone MS; Kaplan H
    Cell; 1978 Dec; 15(4):1323-30. PubMed ID: 282012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein synthesis by rat hepatoma x mouse teratocarcinoma somatic cell hybrids.
    Wray LK; Jaeckle HK
    Somatic Cell Genet; 1983 Jan; 9(1):111-9. PubMed ID: 6836448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrids between F9 nullipotent teratocarcinoma and thymus cells produce multidifferentiated tumors in mice.
    Rousset JP; Bucchini D; Jami J
    Dev Biol; 1983 Apr; 96(2):331-6. PubMed ID: 6832476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 5-azacytidine treatment on mouse embryonal carcinoma cells.
    Cremisi C
    J Cell Physiol; 1983 Aug; 116(2):181-90. PubMed ID: 6190823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.